Cargando…
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model was shown to evoke a sequence of immune responses that lead to disease modification. Here, blocking...
Autores principales: | Rosenzweig, Neta, Dvir-Szternfeld, Raz, Tsitsou-Kampeli, Afroditi, Keren-Shaul, Hadas, Ben-Yehuda, Hila, Weill-Raynal, Pierre, Cahalon, Liora, Kertser, Alex, Baruch, Kuti, Amit, Ido, Weiner, Assaf, Schwartz, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349941/ https://www.ncbi.nlm.nih.gov/pubmed/30692527 http://dx.doi.org/10.1038/s41467-019-08352-5 |
Ejemplares similares
-
Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology
por: Baruch, Kuti, et al.
Publicado: (2015) -
Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner
por: Deczkowska, Aleksandra, et al.
Publicado: (2017) -
Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis
por: Tsitsou-Kampeli, Afroditi, et al.
Publicado: (2023) -
Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
por: Baruch, Kuti, et al.
Publicado: (2020) -
Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
por: Ben-Yehuda, Hila, et al.
Publicado: (2021)